Outlook Therapeutics director Faisal Ghiath Sukhtian acquires 95,398 common shares for $99,962.34
OTLK•Director share purchase
- Outlook Therapeutics director Sukhtian Faisal Ghiath bought 95,398 common shares at $1.05 per share.
- He reported direct ownership of 220,972 shares following the purchase.
